Cancer Immunotherapy and Biomarkers
Cancer Immunotherapy and Biomarkers is a topic indexed in ScholarIQ from OpenAlex.
What is known about Cancer Immunotherapy and Biomarkers?
This cluster of papers focuses on the advances in cancer immunotherapy research, particularly in the context of immune checkpoint blockade targeting PD-1 and PD-L1, the impact of tumor microenvironment, biomarkers for immunotherapy response, T-cell exhaustion, neoantigens, tumor mutational burden, immune-related adverse events, and the exploration of combination therapies. The research also delves into the intricate mechanisms of cancer immunoediting.
How many works does Cancer Immunotherapy and Biomarkers have?
Cancer Immunotherapy and Biomarkers has 145,901 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Cancer Immunotherapy and Biomarkers have?
Cancer Immunotherapy and Biomarkers has 2,861,634 citations in the OpenAlex counts ScholarIQ stores.
What is the OpenAlex record for Cancer Immunotherapy and Biomarkers?
The OpenAlex for Cancer Immunotherapy and Biomarkers is on the source record.